Standardised Hospital Rates and Universal NHCX: Reading the 28 August Health Sub-Committee for FY28 GMC

IRDAI issued a press release on 29 August 2026 covering the 3rd Meeting of the IAC Sub-Committee on Health Insurance. The meeting itself was held on 28 August 2026 and carried forward discussions from the sub-committee's second sitting on 17 July 2026. The stated purpose of the exercise is threefold: building customer trust in health insurance, improving the economic value the product delivers, and increasing penetration.

Four items came out of the deliberations:

1. Simplification of policy wording.
2. Strengthening underwriting so that claim issues are minimised at the point of claim rather than argued after it.
3. Standardisation of hospital treatment rates.
4. Universal integration with the National Health Claims Exchange (NHCX).

None of these is a circular yet. A sub-committee discussion is not a regulation, and a benefits head who rewrites a renewal strategy on the strength of a press release is buying a risk they do not need. The useful reading is different: the sub-committee's agenda tells you which cost drivers the regulator has decided are structural, and therefore which of your own programme's problems are likely to be addressed by market-wide change versus which you will have to solve yourself.

Two of the four items sit directly on a corporate group mediclaim account. Hospital tariff differential is, for most large employers, the single largest determinant of the claims ratio that drives the next renewal quote. And universal NHCX participation would change the evidence trail behind every cashless denial your employees experience.

The sub-committee has four members and is chaired by IRDAI Chairman Ajay Seth. The other members are IRDAI Member Deepak Sood, Dr Indu Bhushan, former Chief Executive Officer of the National Health Authority, and Monika Halan, the personal-finance writer. Insurance-sector invitees include the chief executives of ICICI Lombard, Aditya Birla Health and Niva Bupa. Experts from the World Bank and the Asian Development Bank have been inducted into the process.

Read the composition as a signal about the direction of travel.

Dr Bhushan ran the National Health Authority, the agency that built NHCX and operates Ayushman Bharat PM-JAY. PM-JAY works on a defined package-rate schedule: a listed procedure carries a listed price, and empanelled hospitals accept it as a condition of empanelment. A former NHA chief executive sitting on a sub-committee that is discussing standardised hospital treatment rates is not a coincidence of scheduling. The reference model for what standardisation could look like already exists in the public scheme and has been operated at national scale.

The two multilateral development banks point at the penetration objective. Both run long-standing health-financing programmes, and their induction suggests the sub-committee is framing health insurance as a health-financing question rather than only a product-design one. Three insurer chief executives in the room, two of them from standalone health insurers, means the industry cost base will be argued rather than presented.

One caution on all of it. A sub-committee of the Insurance Advisory Committee advises rather than legislates. Standardised hospital tariffs in particular would need agreement with hospitals, or bargaining power over them, and hospitals are not regulated by IRDAI. Expect movement through empanelment terms and network contracting rather than through an insurance regulation alone.

Most corporate benefits teams analyse their group mediclaim claims ratio through utilisation: how many employees claimed, how many dependants, which conditions, which age bands. That analysis is worth doing and it explains part of the picture. It does not explain the part that moves money the fastest.

The larger variable is price per event. The same procedure, on the same clinical protocol, with the same length of stay, is billed at materially different amounts across hospitals in the same city, and is billed differently to a cash patient, to a retail policyholder, to a corporate group policy and to a government scheme beneficiary. When a corporate policy is known to carry a high sum insured, no room-rent capping and a large covered population, the billed amount for a given admission tends to sit at the upper end of that spread.

This is why two employers with near-identical demographics and admission counts can arrive at renewal with claims ratios far apart. One population admitted into a network where the average billed amount per admission was controlled. The other did not.

What the standardisation proposal would change

If treatment rates for defined procedures were standardised across the network, the corporate-specific loading embedded in hospital billing would compress. The direct effect on a corporate account would be on the claims ratio, and the claims ratio is the input that determines the loading at renewal. This is the mechanism by which a hospital-side reform reaches an employer's premium line, and it is worth being precise about it, because the effect is second-order and delayed by a full policy year.

The corollary is uncomfortable. If your programme's current claims ratio is being driven by tariff differential rather than by genuine morbidity, then a standardisation regime would eventually help you. Until it arrives, that differential is entirely yours to manage, and the levers are network design, tariff agreements and pre-authorisation discipline rather than benefit cuts. We set out the provider-economics view of this in more detail in why hospital cost base drives the group health renewal.

NHCX is the National Health Authority's claims exchange: a common protocol for exchanging pre-authorisation requests, claim submissions, queries and adjudication outcomes between hospitals, insurers and third-party administrators in a structured digital format. Today participation is partial. Some insurers are live, some hospitals are live, and a large volume of cashless traffic still moves over insurer portals, TPA portals, email and fax.

Universal integration, if it lands, changes three operational facts for a corporate programme.

Denials acquire a machine-readable reason code. When a cashless pre-authorisation is declined today, the employee frequently receives an unstructured message relayed by the hospital insurance desk, and the benefits team hears about it as a complaint rather than as a data point. A structured exchange carries a coded reason and a timestamp. That converts denial handling from anecdote to a measurable queue.

Turnaround becomes attributable. When an authorisation takes six hours today, nobody can say whether the delay sat with the hospital desk, the TPA or the insurer. A common exchange with timestamps at each hop makes the delay attributable to a party. For a benefits team that has been told for years that every delay was somebody else's fault, this is the most useful change on the list.

Your service-level clauses become enforceable. Turnaround commitments written into a group policy or into a TPA service agreement have historically been unenforceable because nobody held neutral evidence of the clock. Structured exchange data supplies that evidence.

The operational rebuild that sits behind this is covered in rebuilding the group-health claims desk around NHCX.

The two remaining agenda items are usually read as retail-market concerns. Both have a group corollary worth naming.

Simplified policy wording. A mid-size employer's group mediclaim policy often carries a base wording plus a stack of endorsements accumulated across insurer and broker changes. The employee-facing benefit summary and the operative policy wording drift apart, and the gap surfaces at claim stage as a dispute over what was covered. A market-level simplification exercise will not tidy your endorsement stack. That is a renewal task you can run this year: reconcile the benefit summary circulated to employees against the operative wording, line by line, before the divergences become claims.

Strengthened underwriting to minimise claim issues. The sub-committee's framing is that many claim disputes originate in weak underwriting at inception rather than in bad faith at claim. For group business, where individual medical underwriting is not performed, the equivalent is disclosure quality at the programme level: accurate census data, accurate declaration of pre-existing conditions where the policy prices them, correct classification of dependants, and correct treatment of mid-term additions.

An insurer that has priced on a poor census has priced badly, and the correction arrives either as a mid-term loading or as a hostile renewal. Census hygiene is the cheapest underwriting-side improvement available to a benefits team, and it is almost always the one deferred.

The reform discussion is happening in a market that is growing quickly on the retail side. A Kotak Securities note reported by ANI on 20 August 2026 put health premium growth at 26% year on year in July 2026, with retail health growing at 31%.

Two things follow for a corporate buyer.

First, retail health outpacing the overall health segment means group business is growing more slowly than the headline. Group mediclaim has been a volume-heavy, margin-thin line for Indian general insurers for a long time, and when retail is compounding at 31%, an insurer's appetite for underpriced group business narrows. A corporate with a poor claims ratio should expect less patience at renewal, not more.

Second, the penetration objective the sub-committee has set itself is largely a retail objective. Corporate group cover already reaches a substantial share of the organised workforce. The reforms that would help penetration, meaning simpler wordings and fewer denial disputes, arrive at a corporate programme as service-quality improvements rather than as price relief.

Neither point argues for waiting. The gap between a quoted renewal loading and the published medical trend is where the negotiation happens, and closing it is covered in reading a GMC renewal loading against benchmark medical trend.

Treat the sub-committee's agenda as a specification for the data and contract terms you should be securing now. Everything below is achievable inside a normal renewal cycle and is worth doing whether or not the proposals land.

Contract and data terms to ask for

1. Claim-level data with hospital identity. Not a summary claims ratio. A line-level extract with hospital name, procedure, billed amount, approved amount, deduction reason and admission dates, delivered quarterly. Without hospital identity you cannot see tariff differential at all.
2. Denial and pre-authorisation reason codes. Ask for coded reasons and the timestamp at each stage. Where the insurer and TPA are already on NHCX, ask specifically for the exchange-sourced fields rather than a portal export.
3. Turnaround reporting split by party. Hospital desk, TPA, insurer. Written as a reporting obligation in the service agreement, not as a verbal assurance.
4. A network-tariff schedule for your top hospitals. For the ten to fifteen hospitals that account for the bulk of your admissions, ask what package rates apply to your policy.
5. A change-in-law or regulatory-change clause. If standardised tariffs are notified mid-term, you want a defined mechanism for the benefit to reach the account rather than an argument about it.

Programme design decisions

• Concentrate volume where you can negotiate tariffs. A dispersed network with no volume anywhere gives you no bargaining position at any hospital.
• Reconcile the endorsement stack to one operative wording before the next renewal quote is prepared.
• Fix the census on the three fields named earlier.
• Instrument denials as a queue with an owner, so that when structured reason codes do arrive, you have somewhere to put them.

A programme that has secured those data terms and made those design decisions will convert a standardisation regime into a lower claims ratio within one policy year. A programme that has not will still be arguing about whose fault the delay was.

Discipline matters here, because the temptation to build a reform into a budget before it exists is real and the downside is asymmetric.

Do not assume a tariff standardisation regime in your FY28 premium budget. There is no notified framework, no timeline and no published scope of covered procedures. Hospitals sit outside IRDAI's regulatory perimeter, so any tariff regime would move through empanelment terms, state health authorities or a negotiated arrangement with hospital associations. That is a longer road than a circular.

Do not assume universal NHCX integration by a particular date. It depends on hospital-side readiness across a very large and varied provider base, and partial adoption produces partial benefit.

Do not assume lower hospital tariffs translate one for one into lower premium. The claims ratio improves first, in the year after tariffs change, and the pricing benefit follows at the renewal after that, subject to the insurer's combined ratio and market conditions.

What you can rely on is direction. The regulator has named hospital pricing and claims-data plumbing as the structural problems in Indian health insurance, in a forum chaired by the IRDAI Chairman and attended by three insurer chief executives. Programmes that already hold clean, hospital-identified claims data and enforceable service terms will convert that direction into savings faster than programmes that hold a quarterly summary and a relationship. Ask for the data at this renewal. The rest follows from having it.

The health insurance account is the one line where an employer holds usable data of its own. Use it.